The eye is the only place in the body where a clinician can look directly at blood vessels and nerve tissue, with no surgery. A new paper in Ophthalmology argues that imaging it could help detect disease far beyond the eye. That includes diabetes, cardiovascular disease, and kidney and neurodegenerative

The Alliance for Healthcare from the Eye convened clinicians, industry leaders, regulators, payers, and health system innovators in Orlando on October 17, 2025, for a working meeting focused on advancing oculomics—the use of ocular data, particularly retinal imaging, to detect and manage systemic disease—and translating innovation into real-world impact. The

LA JOLLA, CA AND RESTON, VA, October 14, 2025 – The Alliance for Healthcare from the Eye (AHE) and the Collaborative Community on Ophthalmic Innovation (CCOI) have announced a strategic partnership to accelerate the global adoption of oculomics in healthcare, referred to as Healthcare from the EyeTM. Together, they will

SALT LAKE CITY, UT, May 13, 2025 — A pioneering coalition of healthcare leaders announced the launch of the Alliance for Healthcare from the Eye (AHE) at the Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City. AHE is an ambitious cross-sector initiative to harness the

Abstract Importance Oculomics is the science of analyzing ocular data to identify, diagnose, and manage systemic disease. This article focuses on prescreening, its use with retinal images analyzed by artificial intelligence (AI), to identify ocular or systemic disease or potential disease in asymptomatic individuals. The implementation of prescreening in a